Adsense

Friday, August 12, 2016

Type 2 Diabetes Treatment: What Is MondoA?

Type 2 diabetes affects about 8% of Americans and another 25% of the population is at risk because of obesity. The condition accounts for as much as 20% of all healthcare costs in the U.S.

Photo Credit: Drug Watch

A protein called MondoA has been identified by researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) as a new potential target for drugs to prevent Type 2 Diabetes. The chronic condition accounts for between 85 and 95% of all people with diabetes.

Insulin resistance, in which insulin no longer causes the body's cells to take up the glucose from a meal and use it for energy, leads to Type 2 Diabetes. Following this, glucose continues to circulate in the blood, stimulating the pancreas to make more and more insulin, which eventually becomes so stressful that the insulin-producing cells die. This results in diabetes as the pancreas can no longer produce enough insulin to control blood glucose.

Read full article at Medical Daily and view video


No comments: